Biotechnology
-
Technology & Infrastructure · Models & LLMs AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study
Insider Brief An artificial intelligence-designed drug for a deadly lung disease produced protein changes associated with lower biological age, offering early evidence that AI-discovered medicines could be evaluated for effects beyond the diseases they… -
Technology & Infrastructure · Models & LLMs Can We Make Protein Models Explainable? Sparse Autoencoders Bring Clarity to AI in Drug Discovery
-
Business & Markets · Startups Plexision Announces Funding to Bring Artificial Intelligence to Transplant Outcome Care
-
Business & Markets · Startups ReviR Therapeutics Raises $30M Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders
-
Business & Markets · Enterprise AI Biotech Xaira Grabs $1 Billion to Re-Engineer Drug Development
-
Business & Markets · Startups University of Bristol Stem Cell Spinout Secures £7.6M Seed Funding
-
Business & Markets · Startups Unnatural Products, Inc. Announces $32 Million in Series A Funding to Pair AI And Chemistry to Target Therapeutics
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.